// App-Quantinova.ai

: DNA-Demethylating Agents Combined with Anti-PD-1 Inhibitors Showed Activity in Patients with Relapsed or Refractory Extranodal NK/T Cell Lymphoma Who Have Failed Immunotherapy: An Exploratory Study

Researchers

Presenter

  • Gao Yan

Principal Investigators

  • Cheng Huang

  • Xue-Ping Li

  • Xiaoxiao Wang

  • Bing Bai

  • Yanxia He

  • Liqin Ping

  • Huiqiang Huang

Medical Centers

  • Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

  • Guangzhou, China

  • Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • T-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Asparaginase

  • Vidaza

  • Decitabine

Outcome

  • N/A

Study Design

  • Safety

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved